Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Withdrawn 2Completed 2

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 10Head & Neck 7Dermatologic 4Tumor-Agnostic 3Thoracic 1

Conditions

Keratosis, Actinic 23Skin Neoplasms 7Melanoma 7Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Carcinoma, Squamous Cell 4Carcinoma, Renal Cell 3Stomach Neoplasms 2Ovarian Neoplasms 2Neoplasms, Basal Cell 2Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Merkel Cell 2Carcinoma, Basal Cell 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Diseases 1Sezary Syndrome 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Squamous Cell 1

Interventions

pembrolizumab 9Nivolumab 4Fluorouracil 4Mohs Surgery 3talimogene laherparepvec 2atezolizumab 2Therapeutics 2Photochemotherapy 2Petrolatum 2Paclitaxel 2Niacinamide 2Aminolevulinic Acid 2tozuleristide 1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1selinexor 1regorafenib 1peginterferon alfa-2b 1peginterferon alfa-2a 1osimertinib 1nanocis 1methyl 5-aminolevulinate 1fludarabine 1daromun 1cobimetinib 1cemiplimab 1avelumab 1aldesleukin 1aflibercept 1afamelanotide 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Fluorouracil × Dermatologic × Clear all
NCT04329221 2025-05-07

Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

NCT04642287 2025-05-07

Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients

Massachusetts General Hospital

Phase 2 Withdrawn
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms, Keratosis, Actinic

NCT02218164 2022-10-07

Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
8 enrolled 11 charts
Dermatologic

Carcinoma, Squamous Cell, Neoplasm Metastasis, Skin Neoplasms

NCT00847912 2021-06-11

VAKCCT

VA Office of Research and Development

Phase 4 Completed
954 enrolled 11 charts
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Neoplasms, Neoplasms by Site, Skin Diseases, Skin Neoplasms, Neoplasms, Basal Cell, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡